CD63 and neoplasm: To examine whether intravenously administered CEC‐sEVs reach to sciatic nerves and tumours, CEC‐sEVs carrying CD63‐GFP (GFP‐sEVs) were intravenously administered to tumour‐bearing mice, and the mice were sacrificed 4 h after GFP‐sEVs administration.